{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:50:45Z","timestamp":1764053445847},"reference-count":115,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.semarthrit.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T07:39:08Z","timestamp":1476862748000},"page":"632-641","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approaches"],"prefix":"10.1016","volume":"46","author":[{"given":"Mariane","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila Tamar","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Milhoransa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odirlei Andr\u00e9","family":"Monticielo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Ver\u00edssimo","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2016.10.005_bib1","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","article-title":"The podocyte\u05f3s response to injury: role in proteinuria and glomerulosclerosis","volume":"69","author":"Shankland","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-physiol-020911-153238","article-title":"Cell biology and pathology of podocytes","volume":"74","author":"Greka","year":"2012","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000072917","article-title":"Podocyte biology and the emerging understanding of podocyte diseases","volume":"23","author":"Barisoni","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib4","doi-asserted-by":"publisher","first-page":"p9","DOI":"10.1159\/000191075","article-title":"Signaling in regulation of podocyte phenotypes","volume":"111","author":"Chuang","year":"2009","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5858\/133.2.201","article-title":"Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy","volume":"133","author":"Barisoni","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1523-1755.2005.67097.x","article-title":"Pathways to nephron loss starting from glomerular diseases-insights from animal models","volume":"67","author":"Kriz","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","article-title":"The spectrum of podocytopathies: a unifying view of glomerular diseases","volume":"71","author":"Wiggins","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.tcb.2007.06.006","article-title":"Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton","volume":"17","author":"Faul","year":"2007","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bbrc.2010.04.069","article-title":"Molecular make-up of the glomerular filtration barrier","volume":"396","author":"Patrakka","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/ncpneph0180","article-title":"Clinical impact of research on the podocyte slit diaphragm","volume":"2","author":"Johnstone","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04662","article-title":"Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib13","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1172\/JCI200112849","article-title":"Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin","volume":"108","author":"Schwarz","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/ng1592","article-title":"TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function","volume":"37","author":"Reiser","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib15","doi-asserted-by":"publisher","first-page":"ra77","DOI":"10.1126\/scisignal.2001200","article-title":"Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels","volume":"3","author":"Tian","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1172\/JCI12539","article-title":"Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton","volume":"108","author":"Takeda","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib17","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1172\/JCI7236","article-title":"Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate","volume":"106","author":"Wharram","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib18","doi-asserted-by":"crossref","first-page":"18908","DOI":"10.1016\/S0021-9258(19)37047-4","article-title":"The receptor for the basement membrane glycoprotein entactin is the integrin alpha 3\/beta 1","volume":"267","author":"Dedhar","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ki.2010.403","article-title":"Defective glycosylation of \u03b1-dystroglycan contributes to podocyte flattening","volume":"79","author":"Kojima","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev.cellbio.21.090704.151217","article-title":"Integrin structure, allostery, and bidirectional signaling","volume":"21","author":"Arnaout","year":"2005","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.7255.1","article-title":"Podocytes","volume":"5","author":"Reiser","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib22","doi-asserted-by":"publisher","first-page":"135608","DOI":"10.1155\/2013\/135608","article-title":"Angiopoietin-like 3 induces podocyte F-actin rearrangement through integrin \u03b1(V)\u03b23\/FAK\/PI3K pathway-mediated Rac1 activation","volume":"2013","author":"Lin","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib23","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib24","doi-asserted-by":"publisher","first-page":"C488","DOI":"10.1152\/ajpcell.00424.2009","article-title":"ANG II promotes autophagy in podocytes","volume":"299","author":"Yadav","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1681\/ASN.2013040362","article-title":"\u03b2-Arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury","volume":"25","author":"Buelli","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2353\/ajpath.2008.070057","article-title":"Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria","volume":"172","author":"Li","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-015-0034-4","article-title":"A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro","volume":"16","author":"Dai","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib28","doi-asserted-by":"publisher","first-page":"37004","DOI":"10.1074\/jbc.M403534200","article-title":"A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis","volume":"279","author":"Schiffer","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib29","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/01.ASN.0000019642.55998.69","article-title":"HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes","volume":"13","author":"Husain","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.15231755.2005.00503.x","article-title":"Podocyte involvement in human immune crescentic glomerulonephritis","volume":"68","author":"Bari\u00e9ty","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10157-003-0259-6","article-title":"The role of podocytes in glomerular pathobiology","volume":"7","author":"Asanuma","year":"2003","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1681\/ASN.2008121226","article-title":"New insights into epithelial-mesenchymal transition in kidney fibrosis","volume":"21","author":"Liu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib33","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/ar3206","article-title":"Disturbances of apoptotic cell clearance in systemic lupus erythematosus","volume":"13","author":"Shao","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib35","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/ni0901-764","article-title":"Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity","volume":"2","author":"Lipsky","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib36","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1172\/JCI23049","article-title":"T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells","volume":"115","author":"Zhu","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1191\/096120300678828703","article-title":"Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus","volume":"9","author":"Wong","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib40","article-title":"Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE","author":"das Chagas Medeiros","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2012.08.018","article-title":"Lupus nephritis: a critical review","volume":"12","author":"Borchers","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib42","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/ar3528","article-title":"Mechanisms of tissue injury in lupus nephritis","volume":"13","author":"Nowling","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib43","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2353\/ajpath.2006.051329","article-title":"Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells","volume":"168","author":"Kalaaji","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib44","doi-asserted-by":"publisher","first-page":"786","DOI":"10.4049\/jimmunol.164.2.786","article-title":"Modulation of renal disease in MRL\/lpr mice genetically deficient in the alternative complement pathway factor B","volume":"164","author":"Watanabe","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05132.x","article-title":"FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus","volume":"1183","author":"Niederer","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib46","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm.2752","article-title":"Taming lupus-a new understanding of pathogenesis is leading to clinical advances","volume":"18","author":"Liu","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/08916934.2010.541170","article-title":"Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens","volume":"44","author":"Mjelle","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/00000441-200008000-00009","article-title":"Urinary podocytes for the assessment of disease activity in lupus nephritis","volume":"320","author":"Nakamura","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib50","first-page":"2358","article-title":"Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis","volume":"34","author":"Wang","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib51","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1177\/0961203310397412","article-title":"Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology","volume":"20","author":"Perysinaki","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib52","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/0961203313517152","article-title":"Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?","volume":"23","author":"Rezende","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib53","first-page":"4600","article-title":"Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis","volume":"8","author":"Santos","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib54","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/0971-4065.83029","article-title":"Increased excretion of urinary podocytes in lupus nephritis","volume":"21","author":"Bollain-Y-Goytia","year":"2011","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1681\/ASN.2004050350","article-title":"Glomerular podocytopathy in patients with systemic lupus erythematosus","volume":"16","author":"Kraft","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1191\/0961203306lu2264oa","article-title":"Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis","volume":"15","author":"Han","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib57","first-page":"245","article-title":"Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?","volume":"32","author":"Guti\u00e9rrez","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib58","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/0961203313477225","article-title":"Proteinuria in membranous lupus nephritis: the pathology is in the podocyte","volume":"22","author":"Desai","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib59","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1093\/ndt\/gfs313","article-title":"Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker","volume":"27","author":"Fukuda","year":"2012","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib60","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1681\/ASN.2013020173","article-title":"Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases","volume":"24","author":"Wickman","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib61","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/1756-185X.12602","article-title":"Biomarkers in lupus nephritis","volume":"18","author":"Misra","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib62","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/sj.ki.5000132","article-title":"Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis","volume":"69","author":"Avihingsanon","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib63","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/ki.2009.75","article-title":"Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis","volume":"75","author":"Avihingsanon","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib64","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/rheumatology\/kep074","article-title":"Urinary FOXP3 mRNA in patients with lupus nephritis\u2014relation with disease activity and treatment response","volume":"48","author":"Wang","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib65","doi-asserted-by":"publisher","first-page":"e110383","DOI":"10.1371\/journal.pone.0110383","article-title":"Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis","volume":"9","author":"Ichii","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib66","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1681\/ASN.2012080849","article-title":"miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1","volume":"24","author":"Zhou","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/197197a0","article-title":"Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice","volume":"197","author":"Helyer","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib69","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/art.1780221105","article-title":"A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation","volume":"22","author":"Murphy","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib70","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1084\/jem.180.6.2341","article-title":"Induction of lupus-associated autoantibodies in BALB\/c mice by intraperitoneal injection of pristane","volume":"180","author":"Satoh","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib71","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000066864","article-title":"The chronic graft-versus-host model of systemic autoimmunity","volume":"6","author":"Eisenberg","year":"2003","journal-title":"Curr Dir Autoimmun"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib72","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/ar3528","article-title":"Mechanisms of tissue injury in lupus nephritis","volume":"13","author":"Hainz","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib73","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/ar3465","article-title":"Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models","volume":"13","author":"Pathak","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00164","article-title":"Breaking immunological tolerance in systemic lupus erythematosus","volume":"5","author":"Pieterse","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib75","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1159\/000334955","article-title":"The proteasome inhibitor bortezomib prevents lupus nephritis in the NZB\/W F1 mouse model by preservation of glomerular and tubulointerstitial architecture","volume":"120","author":"Hainz","year":"2012","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib76","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1111\/j.1365-2567.2008.02948.x","article-title":"Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier","volume":"128","author":"Pawar","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000353093","article-title":"Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models","volume":"38","author":"Kimura","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ddmod.2014.08.002","article-title":"Animal models of renal disease lupus nephritis\u202f: animal modeling of a complex disease syndrome pathology","volume":"11","author":"Mcgaha","year":"2014","journal-title":"Drug Discov Today Dis Model"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib79","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1177\/0961203312451784","article-title":"Early treatment with glucocorticoids or cyclophosphamide retains the slit diaphragm proteins nephrin and podocin in experimental lupus nephritis","volume":"21","author":"Moysiadis","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib81","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/0961203313480398","article-title":"Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model","volume":"22","author":"Cheng","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib82","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains","volume":"148","author":"Andrews","year":"1978","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib83","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1006\/clin.1997.4332","article-title":"Effect of late modulation of nitric oxide production on murine lupus","volume":"83","author":"Oates","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib84","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1046\/j.1523-1755.2002.00230.x","article-title":"Modulation of renal disease in MRL\/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase","volume":"61","author":"Reilly","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib85","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1084\/jem.186.3.365","article-title":"Clinical and serologic manifestations of autoimmune disease in MRL-lpr\/lpr mice lacking nitric oxide synthase type 2","volume":"186","author":"Gilkeson","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib86","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2310\/JIM.0b013e3181889e13","article-title":"Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL\/lpr mice deficient in the NOS2 gene","volume":"56","author":"Njoku","year":"2008","journal-title":"J Invest Med"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib87","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1097\/01.ASN.0000127988.42710.A7","article-title":"Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats","volume":"15","author":"Hoffmann","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib88","first-page":"943","article-title":"Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis","volume":"119","author":"Crowley","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib89","doi-asserted-by":"publisher","first-page":"e0132724","DOI":"10.1371\/journal.pone.0132724","article-title":"Tacrolimus protects podocytes from injury in lupus nephritis partly by stabilizing the cytoskeleton and inhibiting podocyte apoptosis","volume":"10","author":"Liao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib90","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1007\/s11033-012-1501-7","article-title":"PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL\/lpr Mice","volume":"39","author":"Zhai","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib91","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/gene.2014.4","article-title":"BXSB-type genome causes murine autoimmune glomerulonephritis: pathological correlation between telomeric region of chromosome 1 and Yaa","volume":"15","author":"Kimura","year":"2014","journal-title":"Genes Immun"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/271694","article-title":"Murine models of systemic lupus erythematosus","volume":"2011","author":"Perry","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib93","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1038\/srep07290","article-title":"Overexpression of Toll-like receptor 8 correlates with the progression of podocyte injury in murine autoimmune glomerulonephritis","volume":"4","author":"Kimura","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib94","doi-asserted-by":"publisher","first-page":"e16472","DOI":"10.1371\/journal.pone.0016472","article-title":"Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritis","volume":"6","author":"Kimura","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib95","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbmt.2007.12.002","article-title":"Murine models of chronic graft-versus-host disease: insights and unresolved issues","volume":"14","author":"Chu","year":"2008","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib96","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/rheumatology\/39.1.18","article-title":"Systemic lupus erythematosus\u2014messages from experimental models","volume":"39","author":"Gordon","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib97","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1365-2249.2005.02838.x","article-title":"Possible role of autoantibodies against nephrin in an experimental model of chronic graft-versus-host disease","volume":"141","author":"Nagahama","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib98","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.clim.2015.11.010","article-title":"MicroRNA-21 deficiency protects from lupus-like autoimmunity in the chronic graft-versus-host disease model of systemic lupus erythematosus","volume":"162","author":"Garchow","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib99","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","article-title":"Induction of autoimmunity by pristane and other naturally occurring hydrocarbons","volume":"30","author":"Reeves","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib100","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.1073\/pnas.92.24.10934","article-title":"Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB\/c mice treated with pristane","volume":"92","author":"Satoh","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib101","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.4049\/jimmunol.157.7.3200","article-title":"Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane","volume":"157","author":"Satoh","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib102","first-page":"1","article-title":"Reducing progression of experimental lupus nephritis via inhibition of the B7\/CD28 signaling pathway","author":"Huang","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib103","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fimmu.2015.00291","article-title":"Animal models of interferon signature positive lupus","volume":"6","author":"Zhuang","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib104","doi-asserted-by":"publisher","first-page":"e114792","DOI":"10.1371\/journal.pone.0114792","article-title":"Resveratrol possesses protective effects in a pristane-induced lupus mouse model","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib105","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1034\/j.1600-079X.2002.01873.x","article-title":"Melatonin\u05f3s unique radical scavenging properties\u2014roles of its functional substituents as revealed by a comparison with its structural analogs","volume":"33","author":"Poeggeler","year":"2002","journal-title":"J Pineal Res"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib106","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/951210","article-title":"Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice","volume":"2010","author":"Zhou","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-079X.2010.00830.x","article-title":"Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats","volume":"50","author":"Agil","year":"2011","journal-title":"J Pineal Res"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib108","doi-asserted-by":"publisher","first-page":"e111141","DOI":"10.1371\/journal.pone.0111141","article-title":"Mitochondrial and metabolic dysfunction in renal convoluted tubules of obese mice: protective role of melatonin","volume":"9","author":"Stacchiotti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib109","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1476-511X-13-184","article-title":"Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL\/6J model of diabetic nephropathy","volume":"13","author":"Gomes","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib110","article-title":"Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats","author":"Elbe","year":"2014","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib111","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1365-2133.2010.09928.x","article-title":"Copy number variations of the human histamine H4 receptor gene are associated with systemic lupus erythematosus","volume":"163","author":"Yu","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib112","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1124\/jpet.103.061754","article-title":"A potent and selective histamine H 4 receptor antagonist with anti-inflammatory properties","volume":"309","author":"Thurmond","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib113","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.drudis.2014.05.007","article-title":"Histamine H4 receptor antagonists for the treatment of inflammatory disorders","volume":"19","author":"Liu","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib114","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib115","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"369","author":"Yu","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2016.10.005_bib116","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nm.3843","article-title":"Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models","volume":"21","author":"Schiffer","year":"2015","journal-title":"Nat Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216303511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216303511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T01:22:40Z","timestamp":1718846560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017216303511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0049017216303511"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.10.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approaches","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}